top of page



The FDA (CBER) has cleared the ASi Manager-AT as the first and only method for the interpretation and screening for in vitro diagnostics, blood donor and cadaveric (non-heart beating) donor screening. 


The ASiManager-AT™ is a integrated digital particle analyzer that objectively interprets the ASI RPR Card Test for Syphilis. The Analyzer utilizes the proprietary ASI Agglutination Serology Interpretation software and ASI reagents.


Laboratories can now follow the CDC recommended nontreponemal algorithm (RPR/VDRL) while providing objective, standardized test interpretation and realize the benefits of automation and data management.

  • Objective and standardized interpretation

  • Data management

  • Utilizes ASI RPR Card Test for Syphilis

  • Easy-to-use

  • Cost effective

  • Lowest cost per test

  • Increased reliability

  • Optimize Labor Resources

  • Workflow Improvement

  • Network/LIMS capable

  • Laboratory proven

  • Results providers know and trust

  • Throughput- 450 samples/hour

  • FDA 510(k) Cleared for in vitro diagnostic and blood donor and cadaveric screening


Sensitivity: >97.99%

Specificity: >99.7%

Independent Testing Results: 

bottom of page